Impacted Third Molar Tooth Clinical Trial
— GPEOfficial title:
Comparison of The Anti Inflammatory and Analgesic Effect of Ginger and Ibuprofen in Post Surgical Pain Model; a Randomized,Placebo-controlled,Double-blind Clinical Trial
Verified date | September 2011 |
Source | Qazvin University Of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ginger contains constituents with pharmacological properties similar to the novel class of dual-acting NSAIDs. Compounds in this class inhibit arachidonic acid metabolism via the cyclooxygenase (COX) and lipooxygenase (LOX) pathways. These compounds have notably fewer side effects than conventional NSAIDs and now are being investigated as a novel class of anti-inflammatory compounds. Although ginger has potentially strong anti-inflammatory components, its efficacy on acute inflammation was not assessed before. The common postoperative sequelae of surgical removal of impacted teeth are pain, trismus and swelling, related to local inflammatory reaction, with cyclooxygenase and prostaglandins playing a crucial role. NSAIDs (e.g. Ibuprofen) are effective in the management of postoperative dental pain, likely through blockage of prostaglandin synthesis and are commonly used. The efficacy of Ibuprofen in the treatment of postoperative dental pain has been evaluated in several clinical trials. However, NSAIDs are contraindicated in patients with gastrointestinal ulcers, bleeding disorders, and renal dysfunctions. Therefore, there is a need for an effective, oral analgesic with a more favorable safety profile. The primary aim of this study was to investigate the ability of Ginger powder (Zintoma, Goldaru) to reduce postoperative swelling, pain and trismus in an acute pain model.
Status | Unknown status |
Enrollment | 60 |
Est. completion date | October 2011 |
Est. primary completion date | September 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Have at least one mesio-angular impacted mandibular third molar(5-7 difficulty degree) - adults without any kind of systemic disease - adults with at least Diploma educational degree Exclusion Criteria: - history of cold,fever,infection or any other inflammatory conditions during one month before surgery - known allergy to NSAIDs ,ginger or acetaminophen - any kind of hematopoietic or bleeding disorders - pregnancy or lactating - history of peptic ulceration - history of corticosteroid use - duration of surgery more than 30 minutes - any infection, fever or any kind of disease cause on days 1,2 and 3 after surgery - failure to attend for follow up - using any kind of medication other than given drugs until day 5 post operatively - being on anticoagulants except for mini-aspirin (72-325 mg/day) - mentally incapable of understanding or complying with the study protocol or for failing to sign the informed consent |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Qazvin University of Medical Sciences | Qazvin | Qazvin State |
Iran, Islamic Republic of | University of Medical Science | Qazvin |
Lead Sponsor | Collaborator |
---|---|
Qazvin University Of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Decreased amount of cheek swelling after surgery | Using standard calipers, cheek thickness will be measured from the lingual aspect of the mid-portion of the crown of the mandibular 1st molar (on the same side) to the tangent of the skin of the cheek. | 5 days | |
Secondary | Decreased amount of serum CRP levels | A venous blood sample (approximately 4 ml, 2ml for CBC check up and 2 ml for CRP concentration) will be collected to quantitatively assess the CRP concentration after surgery and the second sample will be collected 72 hours postoperatively | 3 days | |
Secondary | Amount of pain severity | using 100mmVAS scale,at 1 hour intervals in the first 12 hours following the surgery and every 6 hours until day 5. | 5 days | |
Secondary | Increased amount of Mouth opening ability | assessed by measuring the distance between the upper and lower central incisal edges at maximal mouth opening on days 0 (baseline) and 1,3 and 5 post operatively. | 5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06023524 -
The Effectiveness of Laser Acupuncture and Standard Medication Therapy on Mandibular Post-Odontectomy Patients
|
N/A | |
Completed |
NCT02547896 -
Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction.
|
Phase 4 | |
Completed |
NCT05684601 -
Impact of 3D Intraoral Scanning on Postsurgical Evaluation of Mandibular Third Molar Surgery
|
N/A | |
Completed |
NCT05170516 -
The Effect of Saline Irrigation at Different Temperatures on Pain, Edema, and Trismus After Impacted Third Molar Surgery
|
N/A | |
Completed |
NCT02481700 -
Epidemiological Study on the Surgical Removal of Third Molars
|
||
Completed |
NCT05488028 -
3D Evaluation of Facial Swelling Post Impacted Lower Third Molars Surgery: RCT
|
N/A | |
Completed |
NCT05679973 -
Evaluation of the Efficacy of Polybutester Suture on Postoperative Complications in Lower Impacted Third Molar Surgery
|
N/A | |
Recruiting |
NCT03741894 -
Examination of the Prevention and Treatment Modalities of Alveolitis in Relation With Impacted Teeth Surgery
|
Phase 4 | |
Completed |
NCT06017570 -
Risk Factors for Distal Caries of Second Molars Adjacent to Mandibular Impacted Third Molars
|
N/A | |
Completed |
NCT03894722 -
Effects of Polyvinylpyrrolidone Iodine on Postoperative Trismus and Swelling During Impacted Third Molar Surgery
|
Phase 4 | |
Completed |
NCT02831374 -
Effectiveness of Platelet Rich Plasma in Wound Healing
|
Phase 0 | |
Completed |
NCT02837614 -
Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery
|
Phase 0 | |
Completed |
NCT02494856 -
Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal
|
Phase 4 | |
Completed |
NCT02450487 -
Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery
|
Phase 4 | |
Completed |
NCT05545553 -
Piezosurgery and Conventional Rotary Instruments on Third Molar Surgery
|
N/A | |
Recruiting |
NCT03619460 -
Clinical Efficacy of a New Piezoelectric Technique for Wisdom Teeth Extraction
|
N/A | |
Not yet recruiting |
NCT05143359 -
Accuracy of Variables for Impacted Mandibular Third Molar Surgery
|
N/A | |
Completed |
NCT03784638 -
Comparison of Two Different Flap Designs for Bilateral Impacted Mandibular Third Molar Surgery
|
N/A | |
Completed |
NCT03752255 -
Verbal and Visual Information Techniques on Anxiety in Third Molar Surgery
|
N/A | |
Active, not recruiting |
NCT04349579 -
Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine
|
Phase 4 |